AI Assistant
Blog
Pricing
Log In
Sign Up
Projected risks and costs of cardiovascular disease due to increased systolic blood pressure associated with use of rofecoxib
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
